About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 5458 record(s)
Req # A-2023-001112
Email exchange between Health Canada and Matthew Horwood and/or Noe Chartier from Epoch Times Canada starting July 2023 to November 28, 2023 regarding questions and responses to those questions which address the plasmid contamination, genomic integration, Simian Virus 40 (SV40), residual Deoxyribonucleic Acid (DNA) and other related issues discovered by Kevin McKernan, Philip Buckhaults and other scientists.Organization: Health Canada
March 2024
Req # A-2023-001122
With respect to the Pfizer report entitled 125742 S1 M2 24 nonclinical-overview, provide: the date it was received; the date when the review was completed and by whom including expertise/specialty; findings including: identified risks of the vaccine; potential risks of the vaccine; missing information at the writing of this report.Organization: Health Canada
March 2024
Req # A-2023-001123
With respect to the Pfizer report entitled 125742_S1_M5_5351_c4591001-interim-mth6-adverse-events, provide: the date it was received; the date when the review was completed and by whom including expertise/specialty; findings including: identified risks of the vaccine; potential risks of the vaccine; missing information at the writing of this report.Organization: Health Canada
March 2024
Req # A-2023-001125
With respect to the Pfizer report entitled 125742_S1_M5_5351_bnt162-01-interim3-adverse-events, provide: the date it was received; the date when the review was completed and by whom including expertise/specialty; findings including: identified risks of the vaccine; potential risks of the vaccine; missing information at the writing of this report.Organization: Health Canada
March 2024
Req # A-2023-001157
Records detailing costs associated with personal drivers for your executive team. Include staffing costs for any drivers on-staff, or the costs of hiring them on a as-needed basis. Also include details for any vehicles purchased, or any vehicle maintenance costs. Limit time frame: 2018 and 2023.Organization: Health Canada
March 2024
Req # A-2023-001212
Any Screening Acceptance Letter sent by Health Canada to the sponsor of the Second Liraglutide Abbreviated New Drug Submission (ANDS).Organization: Health Canada
March 2024
Req # A-2023-001213
Screenshot of the status page for the Second Liraglutide Abbreviated New Drug Submission (ANDS) on the Drug Submission Tracking System (DSTS) interface.Organization: Health Canada
March 2024
Req # A-2023-001216
An annotated copy of the most recent Certified Product Information Document (CPID) submitted for the Second Liraglutide Abbreviated New Drug Submission (ANDS).Organization: Health Canada
March 2024
Req # A-2023-001349
Number of individuals who have filed legal claims against their doctors involuntary detaining them at a psychiatric facility.Organization: Health Canada
March 2024
Req # A-2023-001370
The names and contact information of all the people who have been officially authorized to participate in the negotiations being conducted by the Working Group for amendments to the International Health Regulations (WGIHR). All official Letters of Delegation of Authority which authorized any employee of the Health Canada to officially represent Canada in the negotiations being conducted by the WGIHR regarding the proposed amendments to the International Health Regulations. Any such authorization RECEIVED by any employee of Health Canada. All links to any such official publications. All communications from the Director-General of the World Health Organization regarding proposed amendments to be considered at the 77th World Health Assembly. The latest version of the proposed amendments to the International Health Regulations.Organization: Health Canada
March 2024